ArticleJACC. CardioOncology2020

Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity.

Nabil E Boutagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.